Concert Bio
PrivateLast Round
Accelerator
Oct 30, 2024
Total Funding Raised
$7.46M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Concert Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in October 2024.
Concert Bio is a biotechnology company that develops microbiome monitoring and optimization tools, including beneficial microbe products, for hydroponic greenhouse growers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concert Bio Comparables
Compare Concert Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FA Bio | 82% | |
| Ceragen | 80% | |
| BioConsortia, Inc. | 80% |
For institutional investors. Book with your work email.
Concert Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 30, 2024 | ||||
| Grant | Dec 5, 2023 | ||||
| Seed | Nov 1, 2023 | ||||
| Grant | Nov 1, 2023 | ||||
| Pre Seed | Aug 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Concert Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Nucleus Capital | Pre Seed |
| Ascension Ventures | Seed |
| EQT Foundation | Accelerator, Seed |
| Climate Capital | Pre Seed |
| Ponderosa Ventures | Pre Seed |
| Innovate UK | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 578% MoM, reaching 1.2K.
- Jan 1, 2026
Operates research greenhouse facilities at the University of Warwick Innovation Campus.
For institutional investors. Book with your work email.
Concert Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Concert Bio's valuation, stock price, and market status.
Is Concert Bio a public or private company?
Concert Bio is a private company.
What is the current stock price of Concert Bio?
Concert Bio is a private company, so its shares have no public market price. Caplight tracks Concert Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Concert Bio worth (valuation)?
Valuation information for Concert Bio is not publicly available.
Can I buy Concert Bio stock?
Concert Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Concert Bio's last funding round?
Concert Bio's most recent funding round was Accelerator on October 30, 2024.
Who are the main investors in Concert Bio?
Key investors in Concert Bio include The Venture Collective.
Will Concert Bio IPO soon?
No public IPO plans have been announced for Concert Bio.
How can I track Concert Bio secondary market activity?
Caplight tracks bids, offers, and trades in Concert Bio's shares on secondary markets.